Drugs / NPH twice-daily
NPH twice-daily
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00687453 Comparator | Feb 2003 → Aug 2009 | type 2 diabetes mellitus | Charles Drew University of Medicine and Science | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPH twice-daily | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00687453 ↗ |
| Known as | human isophane insulin | “NPH (neutral protamine Hagedorn) insulin (human isophane insulin)” PMID 33166419 ↗ Nov 2020 |
| Known as | neutral protamine Hagedorn | “NPH (neutral protamine Hagedorn) insulin (human isophane insulin)” PMID 33166419 ↗ Nov 2020 |
| Modality | Protein / enzyme biologic | “NPH (neutral protamine Hagedorn) insulin (human isophane insulin)” PMID 33166419 ↗ Nov 2020 |